An introduction to bayesian methods in health technology assessmentBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7208.508 (Published 21 August 1999) Cite this as: BMJ 1999;319:508
- David J Spiegelhalter, senior statistician (firstname.lastname@example.org)a,
- Jonathan P Myles, research assistanta,
- David R Jones, professor of medical statisticsb,
- Keith R Abrams, senior lecturer in medical statisticsb
- a MRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 2SR
- b Department of Epidemiology and Public Health, University of Leicester, Leicester LE1 6TP Edited by Nick Black
- Correspondence to: Dr Spiegelhalter
This is the third of four articles
Bayes's theorem arose from a posthumous publication in 1763 by Thomas Bayes, a non-conformist minister from Tunbridge Wells. Although it gives a simple and uncontroversial result in probability theory, specific uses of the theorem have been the subject of considerable controversy for more than two centuries. In recent years a more balanced and pragmatic perspective has emerged, and in this paper we review current thinking on the value of the Bayesian approach to health technology assessment.
A concise definition of bayesian methods in health technology assessment has not been established, but we suggest the following: the explicit quantitative use of external evidence in the design, monitoring, analysis, interpretation, and reporting of a health technology assessment. This approach acknowledges that judgments about the benefits of a new technology will rarely be based solely on the results of a single study but should synthesise evidence from multiple sources—for example, pilot studies, trials of similar interventions, and even subjective judgments about the generalisability of the study's results.
A bayesian perspective leads to an approach to clinical trials that is claimed to be more flexible and ethical than traditional methods,1 and to elegant ways of handling multiple substudies—for example, when simultaneously estimating the effects of a treatment on many subgroups.2 Proponents have also argued that a bayesian approach allows conclusions to be provided in a form that is most suitable for decisions specific to patients and decisions affecting public policy.3
Bayesian methods interpret data from a study in the light of external evidence and judgment, and the form in which conclusions are drawn contributes naturally to decision making
Prior plausibility of hypotheses is taken into account, just as when interpreting the results of a diagnostic test
Scepticism about large treatment effects can be formally …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial